ArticleNeural processing letters2022
Edge Weight Updating Neural Network for Named Entity Normalization.
Article in Neural processing letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intelligent classification and prediction of students' mental health in online learning environments using boosting algorithm and LIWC features.Scientific reports · 2025Article
- Biomedical named entity recognition using improved green anaconda-assisted Bi-GRU-based hierarchical ResNet model.BMC bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Discriminating the matched named entity pairs or identifying the entities' canonical forms are critical in text mining tasks. More precise named entity normalization in text mining will benefit other subsequent text analytic applications. We built the named entity normalization model with a novel edge weight updating neural network. We, next, verify our model's performance on NCBI disease, BC5CDR disease, and BC5CDR chemical databases, which are widely used named entity normalization datasets in the bioinformatics field. We also tested our model with our own financial named entity normalization dataset to validate the efficacy for more general applications. Using the constructed dataset, we differentiate named entity pairs. Our model achieved the highest named entity normalization performances in terms of various evaluation metrics. Our proposed model when tested on four different datasets achieved state-of-the-art results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.